clinical trial · NCT07136558
Evaluation of ICP-B794 in Patients With Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.·phase1·not yet recruiting·n = 410
Advanced Solid TumorsICP-B794
brief summary
An Open-Label, Multi-center, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ICP-B794 in Patients with Advanced Solid Tumors
started
Aug 1, 2025
primary completion
Jun 1, 2029
completion
Dec 1, 2030
last updated
Aug 22, 2025
official title
An Open-Label, Multi-center, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ICP-B794 in Patients With Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol